Raymond James sees strong demand for APOL1-mediated FSGS therapies
Go back to Raymond James sees strong demand for APOL1-mediated FSGS therapies| (NASDAQ: MAZE) | Delayed: 25.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.88 | 52 Week High | $ | |||
| Open | $25.88 | 52 Week Low | $ | |||
| Day High | $25.88 | P/E | N/A | |||
| Day Low | $25.88 | EPS | $ | |||
| Volume | 15 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 503.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $503.25 | 52 Week High | $134.71 | |||
| Open | $503.25 | 52 Week Low | $73.31 | |||
| Day High | $503.25 | P/E | N/A | |||
| Day Low | $503.25 | EPS | $-1.98 | |||
| Volume | 99 | |||||



